AstraZeneca’s Pioneering Research in Heart Failure and ATTR-CM

Mina Makar highlights AstraZeneca’s commitment to advancing heart failure research and innovative therapies, addressing critical needs in cardiovascular health.

Opinion | Mpox: Lessons From 2022 for Future Preparedness

Shah is a an internal medicine physician and hospitalist. The 2022 mpox outbreak caught many off guard, quickly spreading beyond endemic areas in Africa to

September 24, 2024

Bristol Myers nabs approval for Opdivo combo as first-line bladder cancer treatment

Bristol Myers Squibb won another approval for its blockbuster cancer drug Opdivo, this time to treat a type of bladder cancer in combination with chemotherapies,

March 8, 2024

Increase $$ for Physicians, Institute Site-Neutral Payment, MedPAC Report Suggests

Boosting physician fee-for-service (FFS) payment rates and implementing site-neutral payment are among the ideas discussed in the Medicare Payment Assessment Commission’s (MedPAC) June report to

June 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.